Amphastar Pharmaceuticals, Inc. (FRA:29A)

Amphastar Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,085	1,724	2,681	1,267	980	781
Market Cap Growth	-47.53%	-35.67%	111.55%	29.32%	25.47%	-3.21%
Enterprise Value	1,412	2,091	3,018	1,192	972	792
Last Close Price	23.25	35.65	56.00	26.20	20.20	16.30
PE Ratio	11.40	11.19	21.54	14.82	17.94	680.90
PS Ratio	1.76	2.44	4.60	2.71	2.55	2.73
PB Ratio	1.64	2.44	4.63	2.56	2.50	2.13
P/TBV Ratio	6.23	12.60	113.42	2.76	2.74	2.64
P/FCF Ratio	11.24	10.36	20.39	20.79	15.80	40.81
P/OCF Ratio	8.36	8.37	16.15	15.19	11.37	16.68
EV/Sales Ratio	2.27	2.96	5.18	2.55	2.53	2.77
EV/EBITDA Ratio	7.71	8.38	14.03	9.63	11.65	27.85
EV/EBIT Ratio	10.95	10.54	16.70	11.85	15.43	73.07
EV/FCF Ratio	14.63	12.56	22.95	19.55	15.68	41.37
Debt / Equity Ratio	0.85	0.89	0.98	0.19	0.24	0.15
Debt / EBITDA Ratio	3.08	2.46	2.56	0.75	1.05	1.69
Debt / FCF Ratio	5.80	3.78	4.29	1.58	1.48	2.87
Asset Turnover	0.45	0.47	0.57	0.71	0.67	0.57
Inventory Turnover	2.32	2.76	2.78	2.55	2.51	1.99
Quick Ratio	2.07	2.11	1.65	2.79	2.08	1.53
Current Ratio	3.12	3.07	2.17	3.99	3.06	2.49
Return on Equity (ROE)	14.84%	23.26%	23.55%	18.76%	14.16%	0.25%
Return on Assets (ROA)	5.84%	8.31%	11.07%	9.51%	6.88%	1.36%
Return on Capital (ROIC)	6.71%	9.71%	13.18%	11.37%	8.40%	1.64%
Return on Capital Employed (ROCE)	10.30%	14.60%	15.50%	16.60%	12.60%	2.60%
Earnings Yield	8.77%	8.94%	4.64%	6.75%	5.57%	0.15%
FCF Yield	8.90%	9.65%	4.91%	4.81%	6.33%	2.45%
Buyback Yield / Dilution	6.16%	1.78%	-1.09%	-5.31%	-1.34%	1.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.